The Lipid Market, valued at approximately USD 13.63 billion in 2022, has been witnessing steady growth and is anticipated to maintain a healthy growth rate of more than 6.9% over the forecast period ...

At the hospital, she was told an angiogram showed that spasms in her arteries had led to a second heart attack. The 70% ...

Hyperbaric oxygen therapy has been approved as a complementary treatment for certain medical conditions, but some claim it ...

Adding two weeks of continuous positive airway pressure for preterm infants in the hospital substantially improves lung ...

HBOT has become popular outside of the medical setting among professional athletes and biohackers. But does it work?

Bristol Myers phase III study evaluating Camzyos for the treatment of adult patients with non-obstructive hypertrophic cardiomyopathy fails to meet its dual-primary endpoints.

Introduction NurExone (TSXV:NRX) an innovative Canadian biopharmaceutical company, has reached a significant milestone in its efforts to revolutionize spinal cord injury treatments. The company ...

Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New York Heart Association (NYHA) ...

A recent report from the Office for National Statistics revealed that older people continue to register the highest rates of drug misuse mortality. According to the ONS, there were 1,118 deaths ...

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...

Speaking to The Post, the veteran heart doctor tackled a drug that is commonly prescribed to help children perform better on tests and sports — a phenomenon he calls “borderline child abuse.” ...

Dr. Evan Levine tackles a drug that is often prescribed to help children perform better -- a phenomenon he calls "borderline child abuse." ...